Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    BioPlus Acquisition Corp.

    NASDAQ: BIOS · Real-Time Price · USD
    10.79
    -0.01 (-0.09%)
    At close: Oct 06, 2023, 9:46 PM

    BioPlus Acquisition Statistics

    Share Statistics

    BioPlus Acquisition has - shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 n/a

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 11.23M

    Failed to Deliver (FTD) Shares

    n/a
    		 100

    FTD / Avg. Volume

    n/a
    		 0.28%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is 1183.3 and the forward PE ratio is null. BioPlus Acquisition's PEG ratio is -8.53.

    PE Ratio

    n/a
    		 1183.3

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 27.4

    P/FCF Ratio

    n/a
    		 -8835.49

    PEG Ratio

    n/a
    		 -8.53
    Financial Ratio History

    Enterprise Valuation

    BioPlus Acquisition has an Enterprise Value (EV) of 6.11B.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 -5220.56

    EV / EBIT

    n/a
    		 -8842.52

    EV / FCF

    n/a
    		 -8842.52

    Financial Position

    The company has a current ratio of 1.04, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 1.04

    Quick Ratio

    n/a
    		 1.04

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -4.27

    Debt / FCF

    n/a
    		 -7.23

    Interest Coverage

    n/a
    		 0.37

    Financial Efficiency

    Return on Equity is 2.32% and Return on Invested Capital is -1.33%.

    Return on Equity

    n/a
    		 2.32%

    Return on Assets

    n/a
    		 2.17%

    Return on Invested Capital

    n/a
    		 -1.33%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 n/a

    Employee Count

    n/a
    		 undefined

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -3.17M

    Effective Tax Rate

    n/a
    		 -158.68%

    Stock Price Statistics

    The stock price has increased by -0.09% in the last 52 weeks. The beta is 0, so BioPlus Acquisition's price volatility has been lower than the market average.

    Beta

    n/a
    		 0

    52-Week Price Change

    n/a
    		 -0.09%

    50-Day Moving Average

    n/a
    		 10.77

    200-Day Moving Average

    n/a
    		 10.54

    Relative Strength Index (RSI)

    n/a
    		 51.09

    Average Volume (20 Days)

    n/a
    		 35,934

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -1.17M

    Operating Income

    n/a
    		 -1.17M

    Net Income

    n/a
    		 5.16M

    EBITDA

    n/a
    		 -1.17M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 0.01
    Full Income Statement

    Balance Sheet

    The company has 140.3K in cash and 5M in debt, giving a net cash position of -4.86M.

    Cash & Cash Equivalents

    n/a
    		 140.3K

    Total Debt

    n/a
    		 5M

    Net Cash

    n/a
    		 -4.86M

    Retained Earnings

    n/a
    		 -14.78M

    Total Assets

    n/a
    		 138.63M

    Working Capital

    n/a
    		 -1.78M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -691.47K and capital expenditures 0, giving a free cash flow of -691.47K.

    Operating Cash Flow

    n/a
    		 -691.47K

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -691.47K

    FCF Per Share

    n/a
    		 0
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    BIOS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 0.08%

    FCF Yield

    n/a
    		 -0.01%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for BIOS.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 7.26

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist